Overview
Ketamine Infusion for Pediatric Patients With Obstructive Sleep Apnea Syndrome (OSAS) After Tonsillectomy
Status:
Completed
Completed
Trial end date:
2018-05-03
2018-05-03
Target enrollment:
0
0
Participant gender:
All
All
Summary
The study will evaluate the post-operative morphine-sparing effect, pain reduction, and side effects of a continuous ketamine infusion after tonsillectomy in pediatric patients.Phase:
Phase 4Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
University of ManitobaTreatments:
Ketamine
Criteria
Inclusion Criteria:- Patients requiring tonsillectomy for diagnosis of sleep disordered
breathing/obstructive sleep apnea that will be admitted for overnight
cardiorespiratory monitoring, based on positive polysomnography test, positive
nocturnal home oximetry, or strong signs/symptoms of OSAS
Exclusion Criteria:
- Patients with significant developmental delay, abnormal airway anatomy, significant
co-morbidities such as cardiac disorders, respiratory disorders, neurological
disorders, anad renal disorders.
- Previous reaction to study medications.
- Postoperative bleeding within the first 24 hours
- Refusal to be involved in the study..